Results 171 to 180 of about 737,831 (320)

Raphin‐1 mediates the survival and sensitivity to radiation of pediatric‐type diffuse high‐grade glioma via phosphorylated eukaryotic initiation factor 2α‐dependent and ‐independent processes

Molecular Oncology, EarlyView.
Raphin‐1 reduces the survival of PED‐DHGG cells and enhances their radiation sensitivity through both PeIF2α‐dependent and PeIF2α‐independent mechanisms. Raphin‐1 sustains elevated levels of PeIF2α, contributing to its PeIF2α‐dependent effects. Additionally, raphin‐1 interacts with CReP to mediate a separate radiosensitizing pathway that operates ...
Karin Eytan, Moshe Leitner, Amos Toren, Shoshana Paglin, Michal Yalon   +4 more
wiley   +1 more source

How to predict effective drug combinations - moving beyond synergy scores. [PDF]

iScience
Eckhart L, Lenhof K, Herrmann L, Rolli LM, Lenhof HP.   +4 more
europepmc   +1 more source

Drug combinations and all cause mortality in heart disease: Dosages and types of ACE inhibitors need to be known [PDF]

, 2005
Frank A Snyder
openalex   +1 more source

Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors

Molecular Oncology, EarlyView.
Inhibition of protein SUMOylation has been shown to block tumorigenesis; however, the specific mechanisms by which SUMOylation controls the tumor‐initiating capacities remain elusive. Li et al. describe the role of Etv1 SUMOylation in cancer stem cells using mouse models of mammary gland tumorigenesis.
Veronika Yevdokimova, Yannick D. Benoit
wiley   +1 more source

Efficacy and safety of drug combinations for chronic pelvic pain: a systematic review. [PDF]

Pain Rep
Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel JC, Doiron RC, Halliday S, Gilron I.   +8 more
europepmc   +1 more source

Efficacy and Safety of Delavirdine Mesylate With Zidovudine and Didanosine Compared With Two-Drug Combinations of These Agents in Persons With HIV Disease With CD4 Counts of 100 to 500 cells/mm3 (ACTG 261)

, 1999
Gerald Friedland, Richard B. Pollard, Brigitte P. Griffith, Michael D. Hughes, Gene D. Morse, Roland Bassett, William W. Freimuth, Lisa M. Demeter, Elizabeth Connick, Thomas R. Nevin, Martin Hirsch, Margaret A. Fischl   +11 more
openalex   +1 more source

Drug combinations and all cause mortality in heart disease: No new insights were gained [PDF]

, 2005
S Björck
openalex   +1 more source

Targeting carbonic anhydrase IX/XII prevents the anti‐ferroptotic effect of stromal lactic acid in prostate carcinoma

Molecular Oncology, EarlyView.
In prostate carcinoma, lactic acid, secreted by highly glycolytic cancer‐associated fibroblasts, is imported into tumor cells through the MCT1 transporter and prevents RSL3 and erastin‐induced ferroptosis (A). Targeting of carbonic anhydrase IX/XII, the main extracellular pH regulators, in tumor and stromal cells reduces microenvironmental acidosis and
Elisa Pardella, Giuseppina Comito, Luigi Ippolito, Erica Pranzini, Marta Iozzo, Giulia Gangarossa, Francesca Virgilio, Silvia Bua, Alessio Nocentini, Giada Sandrini, Nicla Lorito, Marina Bacci, Gabriella Nesi, Pietro Spatafora, Sergio Serni, Claudiu T. Supuran, Andrea Morandi, Paola Chiarugi, Elisa Giannoni   +18 more
wiley   +1 more source

A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia. [PDF]

Cancer Res
Chen Y, He L, Ianevski A, Nader K, Ruokoranta T, Linnavirta N, Miettinen JJ, Vähä-Koskela M, Vänttinen I, Kuusanmäki H, Kontro M, Porkka K, Wennerberg K, Heckman CA, Giri AK, Aittokallio T.   +15 more
europepmc   +1 more source

Drug combinations and all cause mortality in heart disease: Authors' reply [PDF]

, 2005
Julia Hippisley‐Cox, Carol Coupland
openalex   +1 more source